GAY BAUTISTA: Open Payments
NPI 1003323254 · SCHAUMBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,591 in 71 payments from 22 companies in 2025. Trend: 2023 $1,965 · 2024 $2,124 · 2025 $1,591
Food & beverage: $1,591
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $335 |
| AstraZeneca Pharmaceuticals LP | 8 | $160 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $156 |
| ABBVIE INC. | 11 | $149 |
| Dexcom, Inc. | 4 | $130 |
| Lilly USA, LLC | 3 | $91 |
| GlaxoSmithKline, LLC. | 4 | $90 |
| PFIZER INC. | 2 | $53 |
| Seqirus USA Inc | 2 | $52 |
| Astellas Pharma US Inc | 2 | $43 |
Products named: Ozempic, JARDIANCE, AIRSUPRA, Dexcom G6 Transmitter, QULIPTA, Wegovy, SHINGRIX, Veozah.
Industry payments across IL — which companies pay providers there.
